Treatment of head and neck cancer in the elderly.

about

Definitive Intensity-modulated Radiation Therapy in Elderly Patients with Locally Advanced Oropharyngeal Cancer.Cysts and Pseudocysts of the Oral Cavity: Revision of the Literature and a New Proposed Classification

P2860

Q33770819-C1158E16-79D8-4639-A892-787F75CADE29 Q58765958-F46DF3E6-B43F-4376-AD3B-DBB0364EA508

P2860

Treatment of head and neck cancer in the elderly.

Item

http://www.wikidata.org/entity/Q38958367

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment of head and neck cancer in the elderly.

@en

type

Item

label

Treatment of head and neck cancer in the elderly.

@en

prefLabel

Treatment of head and neck cancer in the elderly.

@en

P1476

Treatment of head and neck cancer in the elderly.

@en

P2093

Stefan Hartmann

http://www.w3.org/2001/XMLSchema#string

P2860

Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review

Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia

Immune Checkpoint Blockade in Cancer Therapy

Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker

Human papillomavirus and survival of patients with oropharyngeal cancer.

Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.

P304

1903-1921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1220540

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Grandis

P577

2016-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27643444

http://www.w3.org/2001/XMLSchema#string

Treatment of head and neck cancer in the elderly.

about

P2860

P2860

Treatment of head and neck cancer in the elderly.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698